Health technology assessment (HTA) plays a key role in decisions about the use of medical devices in Canada. This session will cover the role of HTA in the management of medical devices in Canada, the programs in CADTH’s medical devices and clinical interventions portfolio, and CADTH’s COVID-19 response. Updates on other relevant CADTH initiatives will also be provided. The session will include an open forum, where attendees can direct questions to CADTH President and CEO Suzanne McGurn and other senior staff at CADTH.
Questions may be sent by email to Events@cadth.ca.